PROFESSOR EILEEN M. O’REILLY, MD
WINTHROP ROCKEFELLER ENDOWED CHAIR IN MEDICAL ONCOLOGY
SECTION HEAD, HEPATOPANCREATICOBILIARY & NEUROENDOCRINE CANCERS
CO-DIRECTOR MEDICAL INITIATIVES, DAVID M. RUBENSTEIN CENTER FOR PANCREATIC CANCER
CHAIR, HUMAN RESEARCH PROTECTION PROGRAM & IRB
ATTENDING PHYSICIAN, MEMBER, MEMORIAL SLOAN KETTERING CANCER CENTER PROFESSOR OF MEDICINE, WEILL CORNELL MEDICAL COLLEGE
MEMORIAL SLOAN KETTERING CANCER CENTER
Eileen M. O’Reilly, MD Memorial Sloan Kettering Cancer Center Dr. Eileen M. O’Reilly holds the Winthrop Rockefeller Endowed Chair in Medical Oncology at Memorial Sloan Kettering (MSK). She serves as the Section Head for Hepatopancreaticobiliary/ Neuroendocrine Cancers, Gastrointestinal Oncology Service, Co-Director for Medical Initiatives at the David M. Rubenstein Center for Pancreatic Cancer and is an Attending Physician and Member at MSK and Professor of Medicine at Weill Cornell Medical College. Dr. O’Reilly received her medical degree at Trinity College (Dublin University) in Ireland. She completed her residency training in Ireland and Fellowship training at MSK. Dr. O’Reilly has pancreatic and hepatobiliary malignancies as the major focus of her research and clinical activities. Research directions include integration of molecular and genetic-based therapies for the treatment of pancreas cancer along with development of adjuvant and neoadjuvant therapies and identification of biomarkers for therapy selection. Dr. O’Reilly teaches and mentors junior faculty, oncology fellows, residents and medical/other students and has numerous teaching and other awards. Dr. O’Reilly is the Principal Investigator of multiple trials in pancreas cancer and has authored/co-authored > 300 articles, editorials and book chapters. Dr. O’Reilly’s other MSK responsibilities include: Chair of the Human Subjects Research Program (HRPP), Chair of the Institutional Review & Privacy Board (IRB) and Chair of the Continuing Medical Education (CME) committee. Nationally Dr. O’Reilly is Co-Chair of the NCI Alliance Co-Operative Group Gastrointestinal Cancers Committee and serves on the NCI Gastrointestinal Cancers Steering Committee (GISC), Medical and Scientific Advisory Board of Pancreatic Cancer Action Network, American Society of Clinical Oncology (ASCO) Guidelines Committee and the Board of the National Pancreas Foundation.